Public-registry site landscape for NCT07722741, a HCC study sponsored by Geneos Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07722741 (registry record) |
| Sponsor | Geneos Therapeutics |
| Condition(s) | HCC |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
At Johns Hopkins University — one of the facilities listed on this trial — 2 other studies are actively recruiting HCC patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07722741 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →